Cite
HARVARD Citation
Layton, A. et al. (n.d.). Brimonidine gel 0.33% rapidly improves patient‐reported outcomes by controlling facial erythema of rosacea: a randomized, double‐blind, vehicle‐controlled study. Journal of the European Academy of Dermatology and Venereology. pp. 2405-2410. [Online].